Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

Journal article

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Symptoms and SARS-CoV-2 positivity in the general population in the UK.

Journal article

Vihta K-D. et al, (2021), Clin Infect Dis

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections.

Journal article

Eyre DW. et al, (2021), BMC Infect Dis, 21

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

Journal article

Lumley SF. et al, (2021), N Engl J Med, 384, 533 - 540

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.

Journal article

National SARS-CoV-2 Serology Assay Evaluation Group None., (2020), Lancet Infect Dis, 20, 1390 - 1400

Load More